Hillevax

Hillevax FCF Conversion

Delisted

The FCF Conversion Rate (FCF/EBITDA) of Hillevax (HLVX) as of Nov 20, 2026 is 74.23 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was 78.93 % — a change of -5.96% (lower).

FCF Conversion

74.23 %

YoY

-5.96%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of Hillevax is 2024 74.23 % . FCF Conversion Rate (FCF/EBITDA) of Hillevax was 2023 78.93 % . It decreases by -5.96% lower compared to the previous year.

The Hillevax FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2019
77.12 USD
Jan 1, 2020
61.77 USD
Jan 1, 2021
11.88 USD
Jan 1, 2022
26.65 USD
Jan 1, 2023
78.93 USD
Jan 1, 2024
74.23 USD
The Hillevax FCF Conversion history
YEARFCF ConversionYoY
74.23 %-5.96%
78.93 %+196.13%
26.65 %+124.32%
11.88 %-80.76%
61.77 %-19.90%
77.12 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Hillevax Stock analysis

What does Hillevax do? HilleVax, Inc. develops and commercializes novel vaccines, focusing on HIL-214, a bivalent virus-like particle (VLP) vaccine candidate for norovirus-induced acute gastroenteritis. The vaccine combines VLPs for norovirus genotypes GI.1 and GII.4 with an aluminum hydroxide adjuvant to enhance immune response. HIL-214 targets moderate-to-severe cases of norovirus infection, which causes symptoms like diarrhea, vomiting, and dehydration. The company's primary revenue stream will come from the future commercialization of HIL-214 after regulatory approval, with potential sales to healthcare providers and public health programs. Hillevax is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Hillevax stock

FCF Conversion Rate (FCF/EBITDA) of Hillevax is 74.23 % in 2024.

FCF Conversion Rate (FCF/EBITDA) of Hillevax changed from 78.93 % to 74.23 %, representing a -5.96% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) Hillevax since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s Hillevax with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Hillevax

All Key Metrics — Hillevax